JohnstonJ. J.RubinsteinW. S., and FacioF. M., Secondary Variants in Individuals Undergoing Exome Sequencing: Screening of 572 Individuals Identifies High-Penetrance Mutations in Cancer-Susceptibility Genes, American Journal of Human Genetics91, no. 1 (2012): 97–108; NetzerC.KleinC.KohlhaseJ., and KubischC., New Challenges for Informed Consent through Whole Genome Array Testing, Journal of Medical Genetics46, no. 7 (2009): 495–496;OstrerH., Changing the Game with Whole Exome Sequencing, Clinical Genetics80, no. 2 (2011): 101–103.
2.
Id. (Johnston); AshleyE. A.ButteA. J., and WheelerM. T., Clinical Assessment Incorporating a Personal Genome, The Lancet375, no. 9725 (2010): 1525–1535.
3.
MayerA. N.DimmockD. P., and ArcaM. J., A Timely Arrival for Genomic Medicine, Genetics in Medicine13, no. 3 (2011): 195–196SolomonB. D.HadleyD. W., and Pineda-AlvarezD. E., Incidental Medical Information in Whole-Exome Sequencing, Pediatrics129, no. 6 (2012): e1605–e1611WortheyE. A.MayerA. N., and SyversonG. D., Making a Definitive Diagnosis: Successful Clinical Application of Whole Exome Sequencing in a Child with Intractable Inflammatory Bowel Disease, Genetics in Medicine13, no. 3 (2011): 255–262.
4.
SaundersC. J.MillerN. A., and SodenS. E., Rapid Whole-Genome Sequencing for Genetic Disease Diagnosis in Neonatal Intensive Care Units, Science Translational Medicine4, no. 154 (2012): 154ra135.
5.
HastingsR.de WertG., and FowlerB., The Changing Landscape of Genetic Testing and Its Impact on Clinical and Laboratory Services and Research in Europe, European Journal of Human Genetics20, no. 9 (2012): 911–916BieseckerL. G.BurkeW., and KohaneI., Next-Generation Sequencing in the Clinic: Are We Ready?Nature Reviews Genetics13, no. 11 (2012): 818–824.
6.
HowardH. C.BorryP., Personal Genome Testing: Do You Know What You Are Buying?American Journal of Bioethics9, nos. 6–7 (2009): 11–13.
7.
HowardH. C.BorryP., Direct-to-Consumer Genetic Testing: More Questions Than Benefits?Personalised Medicine5, no. 4 (2008): 317–320.
8.
European Society of Human Genetics, Statement of the ESHG on Direct-to-Consumer Genetic Testing for Health-Related Purposes, European Journal of Human Genetics18, no. 12 (2010): 1271–1273; HowardH. C.KnoppersB. M., and BorryP., Blurring Lines: The Research Activities of Direct-to-Consumer Genetic Testing Companies Raise Questions about Consumers as Research Subjects, EMBO Reports11, no. 8 (2010): 579–582.
9.
BorryP.StultiensL., and NysH., Presymptomatic and Predictive Genetic Testing in Minors: A Systematic Review of Guidelines and Position Papers, Clinical Genetics70, no. 5 (2006): 374–381.
10.
German Society of Human Genetics, Statement on Genetic Diagnosis in Children and Adolescents, 1995, available at <http://www.gfhev.de/en/gfh/> (last visited January 20, 2014).
11.
Danish Council of Ethics, Genetic Investigation of Healthy Subjects – Report on Presymptomatic Gene Diagnosis, 2001, available at <http://www.etiskraad.dk/sw293.asp> (last visited January 20, 2014).
12.
BorryP.Evers-KieboomsG., and CornelM. C., Genetic Testing in Asymptomatic Minors: Recommendations of the European Society of Human Genetics Recommendations of the European Society of Human Genetics, European Journal of Human Genetics17, no. 6 (2009a): 720–721.
13.
Unesco, Universal Declaration on the Human Genome and Human Rights, 1997, Paris.
14.
AndornoR., The Right Not to Know: An Autonomy Based Approach, Journal of Medical Ethics30, no. 5 (2004): 435–439.
15.
FeinbergJ., The Child's Right to an Open Future, AikenW.LaFoletteH., eds., In Whose Child? Children's Rights, Parental Authority, and State Power (Totowa: Adams & Co, 1980): at 124–153.
16.
DavisD. D., Genetic Dilemmas and the Child's Right to an Open Future, Hastings Center Report27, no. 2 (1997): 7–15.
17.
British Society for Human Genetics, Genetic Testing of Children: Report of a Working Party of the British Society for Human Genetics, 2010, available at <http://www.publichealth.ox.ac.uk/ethox/ethox-photo-archive/GTOC_2010_BSHG.pdf> (last visisted January 28, 2014). LaurieG. T., In Defence of Ignorance: Genetic Information and the Right Not to Know, European Journal of Health Law6, no. 2 (1999): 119–132.
18.
Id.
19.
BuchananA. E.BrockD. W., eds., Deciding for Others (Cambridge: University Press, 1989).
20.
DawsonA., The Determination of the Best Interests in Relation to Childhood Immunisation, Bioethics19, no. 1 (2005): 72–89DownieR. S.RandallF., Parenting and the Best Interests of Minors, Journal of Medicine & Philosopy22, no. 3 (1997): 219–231RossL. F., Genetic testing of Adolescents: Is It in Their Best Interest?Archives of Pediatrics and Adolescent Medicine154, no. 8 (2000): 850–852SpenceK., The Best Interest Principle as a Standard for Decision Making in the Care of Neonates, Journal of Advanced Nursing31, no. 6 (2000): 1286–1292; TrauJ. M.McCartneyJ. J., In the Best Interest of the Patient: Applying This Standard to Healthcare Decision Making Must Be Done in a Community Context, Health Progress74, no. 3 (1993): 50–56.
BorryP.GoffinT.NysH., and DierickxK., Predictive Genetic Testing in Minors for Adult-Onset Genetic Diseases, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine75, no. 3 (2008): 287–296.
26.
BorryP.HowardH. C.SéenéecalK., and AvardD., Direct-to-Consumer Genome Scanning Services: Also for Children?Nature Reviews Genetics10, no. 1 (2009c): 8.
27.
BorryP.HowardH. C.SéenéecalK. and AvardD., Health-Related Direct-to-Consumer Genetic Testing: A Review of Companies' Policies with Regard to Genetic Testing in Minors, Famillial Cancer9, no. 1 (2010): 51–59.
28.
HowardH. C.AvardD., and BorryP., Are the Kids Really All Right? Direct-to-Consumer Genetic Testing in Children: Are Company Policies Clashing with Professional Norms?European Journal of Human Genetics19, no. 11 (2011): 1122–1126.
TaborH. K.StockJ., and BrazgT., Informed Consent for Whole Genome Sequencing: A Qualitative Analysis of Participant Expectations and Perceptions of Risks, Benefits, and Harms, American Journal of Medical Genetics158A, no. 6 (2012): 1310–1319.
33.
BieseckerB. B., Future Directions in Genetic Counseling: Practical and Ethical Considerations, Kennedy Insitute of Ethics Journal8, no. 2 (1998): 145–160MahowaldM. B.VerpM. S., and AndersonR. R., Genetic Counseling: Clinical and Ethical Challenges, Annual Review of Genetics32 (1998): 547–559.
34.
AllanD., Ethical Boundaries in Genetic Testing, Canadian Medical Association Journal154, no. 2 (1996): 241–244.
35.
TariniB. A.TercyakK. P., and WilfondB. S., Commentary: Children and Predictive Genomic Testing: Disease Prevention, Research Protection, and Our Future, Journal of Pediatric Psychology36, no. 10 (2011): 1113–1121.
36.
Id.
37.
Id.
38.
VanC. G. El and CornelM. C., Genetic Testing and Common Disorders in a Public Health Framework, European Journal of Human Genetics19, no. 4 (2011): 377–381.
39.
JanssensA. C.van DuijnC. M., Genome-Based Prediction of Common Diseases: Advances and Prospects, Human Molecular Genetics17, no. R2 (2008): R166–R173.
40.
JanssensA. C.van DuijnC. M., An Epidemiological Perspective on the Future of Direct-to-Consumer Personal Genome Testing, Investigative Genetics1, no. 1 (2010): 1–5.
41.
See Tarini, supra note 36.
42.
MihaescuR.MeigsJ.SijbrandsE., and JanssensA. C., Genetic Risk Profiling for Prediction of Type 2 Diabetes, PLoS Currents3 (2011): RRN1208
43.
MihaescuR.Van ZitterenM., and van HoekM., Improvement of Risk Prediction by Genomic Profiling: Reclassification Measures Versus the Area under the Receiver Operating Characteristic Curve, American Journal of Epidemiology172, no. 3 (2010): 353–361.
44.
PaulweberB.ValensiP., and LindströomJ., A European Evidence-Based Guideline for the Prevention of Type 2 Diabetes, Hormone and Metabolic Research42, no. SO1 (2010): S3–S36.
45.
McBrideC. M.KoehlyL. M.SandersonS. C., and KaphingstK. A., The Behavioral Response to Personalized Genetic Information: Will Genetic Risk Profiles Motivate Individuals and Families to Choose More Healthful Behaviors?Annual Review of Public Health31 (2010): 89–103.
46.
ClarkeA., The Genetic Testing of Children: Working Party of the Clinical Genetics Society (UK), Journal of Medical Genetics31, no. 10 (1994): 785–797.
47.
DuncaR. E.DelatyckiM. B., Predictive Genetic Testing in Young people for Adult-Onset Conditions: Where Is the Empirical Evidence?Clinical Genetics69, no. 1 (2006): 8–16.
48.
JamesK. M.CowlC. T., and TilburtJ. C., Impact of Direct-to-Consumer Predictive Genomic Testing on Risk Perception and Worry among Patients Receiving Routine Care in a Preventive Health Clinic, Mayo Clinic Proceedings86, no. 10 (2011): 933–940.
49.
NordgrenA., Neither as Harmful as Feared by Critics Nor as Empowering as Promised by Providers: Risk Information Offered Direct to Consumer by Personal Genomics Companies, Journal of Community Genetics5, no. 1 (2012): 59–68.
50.
WadeC. H.WilfondB. S., and McBrideC. M., Effects of Genetic Risk Information on Children's Psychosocial Wellbeing: A Systematic Review of the Literature, Genetics in Medicine12, no. 6 (2010): 317–326.
51.
PatenaudeA. F., Commentary: Save the Children: Direct-to-Consumer Testing of Children Is Premature, Even for Research, Journal of Pediatric Psychology36, no. 10 (2010): 1122–1127.
52.
European Academies Science Advisory Council, Direct-to-Consumer Genetic Testing for Health-Related Purposes in the European Union, 2012, available at <http://www.easac.eu/fileadmin/Reports/EASAC_Genetic_Testing_Web_complete.pdf> (last visited January 21, 2014); see European Society of Human Genetics, supra note 8.
53.
SuY.HowardH. C., and BorryP., Users' Motivations to Purchase Direct-to-Consumer Genome-Wide Testing: An Exploratory Study of Personal Stories, Journal of Community Genetics2, no. 3 (2011): 135–146.
54.
See Borry, supra note 27.
55.
TercyakK. P.AlfordHensley S., and EmmonsK. M., Parents Attitudes toward Pediatric Genetic Testing for Common Disease Risk, Pediatrics127, no. 5 (2011): e1288–1295 see Hu, supra note 53.
GreenR. C.BergJ. S., and GrodyW. W., ACMG Recommendations for Reporting of Incidental Findings in Clinical Exome and Genome Sequencing, Genetics in Medicine15, no. 7 (2013): 565–574.